Abstract
Objective
Bacterial infections can exacerbate asthmatic inflammation depending on lipopolysaccharide (LPS) composition, the outermost component of cell wall, its exposure timings as well as host’s immune status. In present study, Balb/c mice were exposed to antigen (ovalbumin) and LPS simultaneously to establish an asthmatic model. Curcumin (diferuloylmethane), well known for its anti-inflammatory potential, was administered through intranasal route 1 h before LPS and OVA (ovalbumin) exposure to evaluate its efficacy against airway structural changes.
Methods
Inflammatory cell infiltration in lungs was measured by flow cytometry and further eosinophils were especially measured by immunofluorescence detection of major basic protein (MBP) as marker of eosinophilc granule protein. We also measured reactive oxygen species (ROS) in BALF by spectrofluorometry. MMP-9 activity was evaluated by gelatin zymography and mRNA expressions of MMP-9, TIMP-1, TGF-β1, IL-13, Collagen-1 and TLR-4 were measured in lungs. Protein expression of MAP kinases (P-ERK, P-JNK, P-p38), TLR-4, Cox-2, Lox-5 and Eotaxin was measured by western blotting. Hydroxyproline level and masson’s trichrome staining were used to evaluate collagen deposition in lung.
Results
Exposure to LPS (0.1 µg) exacerbates airway inflammation and induces structural changes in lungs by enhanced ROS production, collagen deposition, expression of genes involved in airway remodeling and activation of MAP kinases pathway enzymes. Intranasal curcumin pretreatment had significantly suppressed inflammatory mediators and airway remodeling proteins.
Conclusion
Our results strongly suggest that intranasal curcumin effectively protects LPS-induced airway inflammation and structural changes by modulating genes involved in airway remodeling in safer way; hence, it can be considered as supplementary alternative towards asthma treatments.
Similar content being viewed by others
References
Al-Alawi M, Hassan T, Chotirmall SH (2014) Transforming growth factor β and severe asthma: a perfect storm. Respir Med 108:1409–1423
Alam R, Gorska MM (2011) Mitogen-activated protein kinase signaling and ERK1/2 bistability in asthma. Clin Exp Allergy 41:149–159
Arima M, Fukuda T (2011) Prostaglandin D2 and TH2 inflammation in the pathogenesis of bronchial asthma. Korean J Intern Med 26:1–8
Belleguic C, Corbel M, Germain N, Lena H, Boichot E, Delaval PH, Lagente V (2002) Increased release of matrix metalloproteinase-9 in the plasma of acute severe asthmatic patients. Clin Exp Allergy 32:217–223
Bergeron C, Al-Ramli W, Hamid Q (2009) Remodeling in asthma. Am Thorac Soc 6:301–305
Bottcher MF, Hmani-Aifa M, Lindstrom A, Jenmalm MC, Mai XM, Nilsson L, Zdolsek HA, Bjorksten B, Soderkvist P, Vaarala O (2004) A TLR4 polymorphism is associated with asthma and reduced lipopolysaccharide-induced interleukin-12 (p70) responses in Swedish children. J Allergy Clin Immunol 114:561–567
Caramori G, Papi A (2004) Oxidants and asthma. Thorax 59:170–173
Chauhan PS, Dash D, Singh R (2014) Intranasal curcumin attenuates airway remodeling in murine model of chronic asthma. Int Immunopharmacol 21:63–75
Chopra P, Kanoje V, Semwal A, Ray A (2008) Therapeutic potential of inhaled p38 mitogen-activated protein kinase inhibitors for inflammatory pulmonary diseases. Expert Opin Investig Drugs 17:1411–1425
Choudhury BK, Wild JS, Alam R, Klinman DM, Boldogh I, Dharajiya N, Mileski WJ, Sur S (2002) In vivo role of p38 mitogen-activated protein kinase in mediating the anti-inflammatory effects of CpG oligodeoxynucleotide in murine asthma. J Immunol 169:5955–5961
Claar D, Hartert TV, Peebles RS Jr (2015) The role of prostaglandins in allergic lung inflammation and asthma. Expert Rev Respir Med 9:55–72
Conroy DM, Williams TJ (2001) Eotaxin and the attraction of eosinophils to the asthmatic lung. Respir Res 2:150–156
Danahay H, Atherton H, Jones G, Bridges RJ, Poll CT (2002) Interleukin-13 induces a hypersecretory ion transport phenotype in human bronchial epithelial cells. Am J Physiol Lung Cell Mol Physiol 282:226–236
Dong L, Li H, Wang S, Li Y (2009) Different doses of lipopolysaccharides regulate the lung inflammation of asthmatic mice via TLR4 pathway in alveolar macrophages. J Asthma 46:229–233
Doreswamy V, Alexis NE, Zhou H, Peden DB (2011) Nasal PMN response to repeated challenge with endotoxin in healthy volunteers. Inhal Toxicol 23:142–147
Douwes J, Gibson P, Pekkanen J, Pearce N (2002) Non-eosinophilic asthma: importance and possible mechanisms. Thorax 57:643–648
Eruslanov E, Kusmartsev S (2010) Identification of ROS using oxidized DCFDA and flow-cytometry. Adv Protoc Oxidative Stress 594:57–72
Fulkerson PC, Fischetti CA, McBride ML, Hassman LM, Hogan SP, Rothenberg ME (2006) A central regulatory role for eosinophils and the eotaxin/CCR3 axis in chronic experimental allergic airway inflammation. Proc Natl Acad Sci 103:16418–16423
Green RH, Brightling CE, Woltmann G, Parker D, Wardlaw AJ, Pavord ID (2002) Analysis of induced sputum in adults with asthma: identification of subgroup with isolated sputum neutrophilia and poor response to inhaled corticosteroids. Thorax 57:875–879
Gundel RH, Letts LG, Gleich GJ (1991) Human eosinophil major basic protein induces airway constriction and airway hyperresponsiveness in primates. J Clin Invest 87:1470–1473
Kim JS, Kang JY, Ha JH, Lee HY, Kim SJ, Kim SC, Ahn JH, Kwon SS, Kim YK, Lee SY (2013) Expression of nerve growth factor and matrix metallopeptidase-9/tissue inhibitor of metalloproteinase-1 in asthmatic patients. J Asthma 50:712–717
Kumari A, Dash D, Singh R (2015) Lipopolysaccharide (LPS) exposure differently affects allergic asthma exacerbations and its amelioration by intranasal curcumin in mice. Cytokine 76:334–342
Kumari A, Dash D, Singh R (2017) Curcumin inhibits lipopolysaccharide (LPS)-induced endotoxemia and airway inflammation through modulation of sequential release of inflammatory mediators (TNF-α and TGF-β1) in murine model. Inflammopharmacology 25:329–341
Kupai K (2011) Gelatin zymography for detection of matrixmetalloproteinase-2 and-9 (MMP-2, MMP-9) from myocardium samples. In a practical manual p 29
Lloyd CM, Hawrylowicz CM (2009) Regulatory T cells in asthma. Immunity 31:438–449
Lowry OH, Rosebrough NJ, Farr AL, Randall RJ (1951) Protein measurement with the folin phenol reagent. J Biol Chem 193:265–275
Makinde T, Murphy RF, Aggarwal DK (2007) The regulatory role of TGF-β in airway remodeling in asthma. Immunol Cell Biol 2007:85–348
Martel-Pelletier J, Lajeunesse D, Reboul P, Pelletier JP (2003) Therapeutic role of dual inhibitors of 5-LOX and COX, selective and non-selective non-steroidal anti-inflammatory drugs. Ann Rheum Dis 62:501–509
McBrien CN, Menzies-Gow A (2017) The biology of eosinophils and their role in asthma. Front Med 4:93
Mohamed GM, Farres MN, Mahmoud H (2012) Interplay between matrix metalloproteinase-9 and tissue inhibitor of matrix metalloproteinase-1 in acute asthma exacerbation and airway remodeling. Egypt J Chest Dis Tuberc 61:35–39
Munitz A, Brandt EB, Mingler M, Finkelman FD, Rothenberg ME (2008) Distinct roles for IL-13 and IL-4 via IL-13 receptor α1 and the type II IL-4 receptor in asthma pathogenesis. Proc Natl Acad Sci 105:7240–7245
Nelson HS, Davies DE, Wicks J, Powell RM, Puddicombe SM, Holgate ST (2003) Airway remodeling in asthma: new insights. J Allergy Clin Immunol 111:215–225
Ohbayashi H, Shimokata K (2005) Matrix metalloproteinase-9 and airway remodeling in asthma. Curr Drug Targets Inflamm Allergy 4:177–181
Oshita Y, KogaT Kamimura T, Matsuo K, Rikimaru T, Aizawa H (2003) Increased circulating 92 kDa matrix metalloproteinase (MMP-9) activity in exacerbations of asthma. Thorax 58:757–760
Peebles RS, Sheller JR (2002) Role of prostaglandins in asthma. Immunol Allergy Clin 22:827–844
Perros F, Lambrecht BN, Hammad H (2011) TLR4 signalling in pulmonary stromal cells is critical for inflammation and immunity in the airways. Respir Res 12:125
Roland NJ, Bhalla RK, Earis J (2004) The local side effects of inhaled corticosteroids: current understanding and review of the literature. Chest 126:213–219
Sackesen C, Karaaslan C, Keskin O, Tokol N, Tahan F, Civelek E, Soyer OU, Adalıoglu G, Uncer A, Birben E, Oner C (2005) The effect of polymorphisms at the CD14 promoter and the TLR4 gene on asthma phenotypes in Turkish children with asthma. Allergy 60:1485–1492
Shim JJ, Dabbagh K, Ueki IF, Dao-Pick T, Burgel PR, Takeyama K, Tam DCW, Nadel JA (2001) IL-13 induces mucin production by stimulating epidermal growth factor receptors and by activating neutrophils. Am J Physiol Lung Cell Mol Physiol 280:134–140
Stelts D, Egan RW, Falcone A, Garlisi CG, Gleich GJ, Kreutner W, Kung TT, Nahrebne DK, Chapman RW, Minnicozzi M (1998) Eosinophils retain their granule major basic protein in a murine model of allergic pulmonary inflammation. Am J Respir Cell Mol Biol 18:463–470
Sumi Y, Hamid Q (2007) Airway remodeling in asthma. Allergol Int 56:341–348
Sutherland ER, Martin RJ (2007) Asthma and atypical bacterial infection. Chest 132:1962–1966
Xue-Xi Y, Fen-Xia L, Wu YS, Wu D, Jia-Yu T, Li M (2011) Association of TGF-[beta] 1, IL-4 and IL-13 gene polymorphisms with asthma in a Chinese population. Asian Pac J Allergy Immunol 29:273
Yang J, Li Q, Zhou XD, Kolosov VP, Perelman JM (2011) Naringenin attenuates mucous hypersecretion by modulating reactive oxygen species production and inhibiting NF-κB activity via EGFR-PI3 K-Akt/ERK MAP kinase signaling in human airway epithelial cells. Mol Cell Biochem 351:29–40
Yang Y, Kim SC, Yu T, Yi YS, Rhee MH, Sung GH, Yoo BC, Cho JY (2014) Functional roles of p38 mitogen-activated protein kinase in macrophage-mediated inflammatory responses. Mediat Inflamm 20:2014
Zhu HT, Bian C, Yuan JC, Chu WH, Xiang X, Chen F, Wang CS, Feng H, Lin JK (2014) Curcumin attenuates acute inflammatory injury by inhibiting the TLR4/MyD88/NF-κB signaling pathway in experimental traumatic brain injury. J neuroinflamm 11:59
Acknowledgements
This work was supported by Department of Science and Technology-Science and Engineering Research Board, New Delhi, India (DST-SERB). Real time PCR (ABI 7500) and flow cytometer (FACS Calibur, BD Biosciences) studies were performed at Central facility of Interdisciplinary Institute of Life Sciences (ISLS), Banaras Hindu University, Varanasi India.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
Authors have no conflict of interest.
Rights and permissions
About this article
Cite this article
Kumari, A., Singh, D.K., Dash, D. et al. Intranasal curcumin protects against LPS-induced airway remodeling by modulating toll-like receptor-4 (TLR-4) and matrixmetalloproteinase-9 (MMP-9) expression via affecting MAP kinases in mouse model. Inflammopharmacol 27, 731–748 (2019). https://doi.org/10.1007/s10787-018-0544-3
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10787-018-0544-3